title: Photodynamic therapy with verteporfin for chronic central serous choroidoretinopathy and idiopathic choroidal neovascularization-first report from the sultanate of oman.
abstract: BACKGROUND
  Central Serous Chorioretinopathy (CSCR) is characterized by accumulation of subretinal fluid, resulting in neurosensory retinal detachment.
  
  
  METHODS
  Interventional study.
  
  
  METHODS
  Five patients (CSCR-3; Idiopathic-2) with Choroidal Neovascularization (CNV) were selected for the study. All patients had Standardized refraction, color photographs, fluorescein angiography (FA), and Photodynamic Therapy (PDT) using verteporfin. Optical Coherence Tomography (OCT) was done wherever applicable. The main outcome measures were improvement or stability in Best Corrected Visual Acuity (BCVA) and FA identified closure of lesions.
  
  
  RESULTS
  Followup period for the CSCR group ranged from 8 to 11 months and for the idiopathic group 12 to 23 months. BCVA improved in 67% eyes in the CSCR group (three eyes). Amongst the idiopathic group (two eyes), one eye gained BCVA by two lines while the other lost one Snellen line from baseline VA. FA identified CNV lesions closed in 67% eyes in the CSCR group and all eyes in the idiopathic CNV group.
  
  
  CONCLUSIONS
  Photodynamic therapy with Verteporfin can be an ideal mode of therapy in chronic CSCR with or without CNV, and idiopathic CNV in terms of improved or stabilized VA, and closure of the CNV lesions. A study involving a larger number of patients as a multicenter trial would add to the authenticity of our observation.
authors.affiliation: Department of Ophthalmology, Sultan Qaboos University, College of Medicine and Health Sciences, Muscat, Sultanate of Oman.
authors.forename: Upender Krishen
authors.initials: UK
authors.lastname: Wali
authors.forename: Nadia
authors.initials: N
authors.lastname: Al-Kharousi
authors.forename: Harith
authors.initials: H
authors.lastname: Hamood